Health Care: Drugs

Isis Pharmaceuticals (ISIS: NASDAQ)

$42.28 n/a | n/a%
09/19/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 147.28M 102.05M 99.09M 108.47M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 147.28M 102.05M 99.09M 108.47M
Selling, General, and Administrative Expenses 14.92M 12.52M 12.79M 11.67M
Research & Development 184.03M 158.46M 157.40M 145.16M
Operating Income before D & A (EBITDA) -51.67M -68.92M -71.10M -48.36M
Depreciation & Amortization 28.68M 30.51M 26.25M 22.55M
Interest Income 2.08M 1.84M 2.41M 3.37M
Other Income - Net 2.38M 15.05M 4.18M -713.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -75.88M -83.94M -94.31M -70.48M
Interest Expense 19.36M 21.15M 16.73M 13.23M
Pre-Tax Income -95.24M -105.09M -111.04M -83.71M
Income Taxes -5.91M -9.11M 11.00K 92.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -60.64M -65.48M -84.80M -61.25M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -60.64M -65.48M -84.80M -61.25M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -60.64M -65.48M -84.80M -61.25M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-60.64M -65.48M -84.80M -61.25M
Preferred Dividends
Net Income Available To Common -60.64M -65.48M -84.80M -61.25M
Basic EPS from Continuing Ops. -0.55 -0.65 -0.85 -0.62
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.55 -0.65 -0.85 -0.62
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.55 -0.65 -0.85 -0.62
Basic Normalized Net Income/Share -0.55 -0.65 -0.85 -0.62
EPS fr Continuing Ops. -0.55 -0.65 -0.85 -0.62
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.55 -0.65 -0.85 -0.62
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.55 -0.65 -0.85 -0.62
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.55 -0.65 -0.85 -0.62
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ISIS

Latest ISIS Headlines from TheStreet

More Financial News for ISIS

Press Releases for ISIS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter